Novo Nordisk secures first two wins in legal battle against compounding pharmacies, wellness centers
Federal judges have blocked two Florida wellness centers from using Novo Nordisk’s trademark to market compounded drugs containing its diabetes and weight loss blockbuster semaglutide.
The judgments, from two separate courts in Miami and Tallahassee, are the first wins in Novo’s legal campaign against what it claims is improper marketing. Novo has filed 12 lawsuits against compounding pharmacies and wellness centers in several states, arguing that misleading advertising is likely to make consumers believe they’re buying authentic Novo products.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.